Free Trial

Lipocine (LPCN) SEC Filings & 10K Form

Lipocine logo
$3.28 -0.03 (-0.91%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$3.42 +0.14 (+4.39%)
As of 03/28/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lipocine SEC Filings

DateFilerForm TypeView
03/26/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
8:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
8:30 AM
Lipocine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
5:04 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:46 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
6:47 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4/A
12/30/2024
7:03 PM
Fogarty Krista (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
7:04 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:06 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
8:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:09 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:37 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:05 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
5:04 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
8:39 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
10:23 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
5:19 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
5:20 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:39 PM
Fink Jeffrey Arvin (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:41 PM
Higuchi John W. (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:43 PM
Jene Jill M. (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:45 PM
Lipocine (Issuer)
Ono Richard Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:48 PM
Lipocine (Issuer)
Papapetropoulos Spyros (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:32 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
4:15 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
5:03 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
5:06 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
5:15 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
05/01/2024
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM
Lipocine (Filer)
Form 424B5
04/26/2024
4:20 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
11:15 PM
Lipocine (Filer)
Form EFFECT
04/23/2024
3:24 PM
Lipocine (Filer)
Form S-3/A
04/23/2024
3:05 PM
Lipocine (Filer)
Form DEF 14A
04/11/2024
6:24 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:LPCN) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners